DE:YPHA / Astellas Pharma Inc. - Depositary Receipt (Common Stock) - Net Long/Short Value

Astellas Pharma Inc. - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US04623U1025
9,20 € 0,00 (0,00%)
2025-09-18
DEL PRIS
DE:YPHA / Astellas Pharma Inc. - Depositary Receipt (Common Stock) - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Nbc Securities, Inc.
Salomon & Ludwin, LLC
GAMMA Investing LLC
JINTX - JOHNSON MUTUAL FUNDS TRUST - Johnson International Fund
Pnc Financial Services Group, Inc.
Skopos Labs, Inc.
Hantz Financial Services, Inc.
Wealth Preservation Advisors, LLC
ENDW - EA Series Trust - Cambria Endowment Style ETF
Rhumbline Advisers
SPWO - SP Funds Trust - SP Funds S&P World (ex-US) ETF
Other Listings
US:ALPMY
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista